menu
    • menu

    Find Soficitinib manufacturers, exporters & distributors on PharmaCompass

    Evonik

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.

    Virtual Booth

    Contact Supplier

    Kewpie is your partner for Sodium Hyaluronate & Hyaluronic Acid// CEP, USDMF, KDMF & JDMF registered.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass

    Synopsis

    Product SearchProduct Search

    Synopsis

    ACTIVE PHARMA INGREDIENTS

    0

    API Suppliers

    API Suppliers

    0

    USDMF

    US DMFs Filed

    0

    CEP/COS

    CEP/COS Certifications

    0

    JDMF

    JDMFs Filed

    0

    EU WC

    EU WC

    0

    KDMF

    KDMF

    0

    NDC API

    NDC API

    0

    VMF

    NDC API

    0

    Listed Suppliers

    Other Suppliers

    0INTERMEDIATES

    REF. STANDARDS OR IMPURITIES

    0

    EDQM

    0

    USP

    0

    JP

    0

    Others

    FINISHED DOSAGE FORMULATIONS

    0

    FDF Dossiers

    FDF Dossiers

    0

    FDA Orange Book

    FDA (Orange Book)

    0

    Europe

    Europe

    0

    Canada

    Canada

    0

    Australia

    Australia

    0

    South Africa

    South Africa

    0

    Listed Dossiers

    Listed Dossiers

    3DRUGS IN DEVELOPMENT

    FDF Dossiers

    DRUG PRODUCT COMPOSITIONS

    0RELATED EXCIPIENT COMPANIES

    0EXCIPIENTS BY APPLICATIONS

    PATENTS & EXCLUSIVITIES

    0

    US Patents

    0

    US Exclusivities

    0

    Health Canada Patents

    API REF. PRICE (USD/KG)

    $
    $ 0

    GLOBAL SALES INFORMATION

    US Medicaid

    NA

    Annual Reports

    NA

    Regulatory FDF Prices

    NA

    API/FDF Prices: Book a Demo to
    explore the features and consider
    upgrading later

    MARKET PLACE

    0

    API

    0

    FDF

    DIGITAL CONTENT

    0

    Data Compilation #PharmaFlow

    0

    Stock Recap #PipelineProspector

    0

    Weekly News Recap #Phispers

    1

    News #PharmaBuzz

    Chemistry

    Click the arrow to open the dropdown
    read-moreClick the button for full data set
    read-moreClick the button for full data set
    Also known as: Soficitinib [inn], Wqe4ath4kc, Schembl22856037, Gtpl14068, Compound 20 [wo2020259584], (3as,6ar)-5-[5-chloro-2-[(1-methyl-1h-pyrazol-4-yl)amino]-4-pyrimidinyl]hexahydro-3a-methyl-beta-oxopyrrolo[3,4-c]pyrrole-2(1h)-propanenitrile
    Molecular Formula
    C18H21ClN8O
    Molecular Weight
    400.9  g/mol
    InChI Key
    OWDNRVGFIXZHAC-KPZWWZAWSA-N
    FDA UNII
    WQE4ATH4KC
    Soficitinib
    1 2D Structure

    Soficitinib

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    3-[(3aS,6aR)-2-[5-chloro-2-[(1-methylpyrazol-4-yl)amino]pyrimidin-4-yl]-3a-methyl-3,4,6,6a-tetrahydro-1H-pyrrolo[3,4-c]pyrrol-5-yl]-3-oxopropanenitrile
    2.1.2 InChI
    InChI=1S/C18H21ClN8O/c1-18-10-26(15(28)3-4-20)7-12(18)8-27(11-18)16-14(19)6-21-17(24-16)23-13-5-22-25(2)9-13/h5-6,9,12H,3,7-8,10-11H2,1-2H3,(H,21,23,24)/t12-,18+/m0/s1
    2.1.3 InChI Key
    OWDNRVGFIXZHAC-KPZWWZAWSA-N
    2.2 Other Identifiers
    2.2.1 UNII
    WQE4ATH4KC
    2.3 Synonyms
    2.3.1 Depositor-Supplied Synonyms

    1. Soficitinib [inn]

    2. Wqe4ath4kc

    3. Schembl22856037

    4. Gtpl14068

    5. Compound 20 [wo2020259584]

    6. (3as,6ar)-5-[5-chloro-2-[(1-methyl-1h-pyrazol-4-yl)amino]-4-pyrimidinyl]hexahydro-3a-methyl-beta-oxopyrrolo[3,4-c]pyrrole-2(1h)-propanenitrile

    7. 2574524-67-5

    8. 3-[(3as,6ar)-2-[5-chloro-2-[(1-methylpyrazol-4-yl)amino]pyrimidin-4-yl]-3a-methyl-3,4,6,6a-tetrahydro-1h-pyrrolo[3,4-c]pyrrol-5-yl]-3-oxopropanenitrile

    9. Pyrrolo[3,4-c]pyrrole-2(1h)-propanenitrile, 5-[5-chloro-2-[(1-methyl-1h-pyrazol-4-yl)amino]-4-pyrimidinyl]hexahydro-3a-methyl-beta-oxo-, (3as,6ar)-

    2.4 Create Date
    2021-01-30
    3 Chemical and Physical Properties
    Molecular Weight 400.9 g/mol
    Molecular Formula C18H21ClN8O
    XLogP31.3
    Hydrogen Bond Donor Count1
    Hydrogen Bond Acceptor Count7
    Rotatable Bond Count4
    Exact Mass Da
    Monoisotopic Mass Da
    Topological Polar Surface Area103
    Heavy Atom Count28
    Formal Charge0
    Complexity655
    Isotope Atom Count0
    Defined Atom Stereocenter Count2
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count1

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search